The trial protocol was approved by the Madrid Region Clinical Research Ethics Committee ( Comit tico de Investigacin Clnica Regional de la Comunidad de Madrid ) on February 8 th 2011, and has been registered with ClinicalTrials.gov number NCT 01476007, and under EUDRACT number 2010-024129-20 [Oral Versus Intramuscular Cobalamin to treat Cobalamin Deficiency: Noninferiority randomised controlled trial, pragmatic and multi-center in the primary healthcare setting (OB12 project)]
Their ability to target specific functions within the body makes them valuable in medical treatments, including those related to prostate health
For example, high-dose intravenous (IV) injections deliver a concentrated amount of the antioxidant directly into the bloodstream
Retention of misfolded TYR proteins in the endoplasmic reticulum results in the loss of pigmentation, which has also been proposed to be one of the major post-translational mechanisms responsible for the effects of resveratrol
If youre not getting enough nutrients, it can show up on your skin in the form of dullness, dark circles, or uneven tone